Production (Stage)
MedX Health Corp
MDX.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -55.27% | 24.84% | 1.51% | -55.49% | 56.63% |
| Total Depreciation and Amortization | -2.33% | 0.00% | -1.15% | -54.21% | 18,900.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 548.41% | 36.08% | -40.49% | 278.91% | -115.91% |
| Change in Net Operating Assets | -16.52% | -229.07% | -75.16% | 1,241.05% | -92.44% |
| Cash from Operations | 16.72% | 7.52% | -63.92% | 25.22% | 3.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -6.62% | 44.37% | 12.14% | -14.98% | 24.53% |
| Total Debt Repaid | 11.32% | -119.65% | -41.80% | -101.97% | 192.09% |
| Issuance of Common Stock | -100.00% | -86.70% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -15.33% | -16.31% | 100.43% | -27.42% | -18.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.92% | -109.98% | 246.35% | -0.85% | -183.06% |